Skip to main content
. Author manuscript; available in PMC: 2024 Jun 3.
Published in final edited form as: Eur J Prev Cardiol. 2024 Jan 10;31(8):1015–1025. doi: 10.1093/eurjpc/zwae009

Table 1. Baseline characteristics of the study population, dichotomised as non-carriers/carriers of the loss-of-function PCSK9 variant rs151193009-T.

rs151193009 genotype
Characteristics CC
(N=69,088)
CT/TT
(N=1,826)
Age (years), mean (SD) 52.1 (10.7) 52.5 (10.9)
Female, % 59.7 61.2
Urban region, % 45.8 47.2
LDL-C (mmol/L), mean (SD) 2.36 (0.69) 1.99 (0.69)
Height (cm), mean (SD) 158.8 (8.3) 159.1 (8.2)
BMI (kg/m2), mean (SD) 23.8 (3.4) 24.0 (3.5)
Waist/hip ratio, mean (SD) 0.88 (0.07) 0.88 (0.07)
SBP (mmHg), mean (SD) 131.5 (21.4) 132.5 (21.8)
DBP (mmHg), mean (SD) 78.0 (11.2) 78.8 (11.5)
Physical activity (MET h/d), mean (SD) 20.6 (14.0) 20.6 (14.3)
High school or higher education, % 21.0 21.8
Household income ≥20,000 yuan, % 40.1 40.4
Current regular alcohol drinking, % 15.5 15.5
Current regular smoker, % 25.9 24.2
Stroke/TIAa, % 1.7 1.7
Coronary heart diseasea, % 3.6 4.2
Hypertension, % 11.6 12.9
Diabetesb, % 6.1 6.2
Taking statins, % 1.9 1.6

BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; MET: metabolic equivalent of task

a

self-reported physician diagnosed.

b

self-reported physician diagnosed or screen-detected at baseline